Showing results (221-230 of 3,013) with videos related to
Sort By:
Pageof 302
Cardiovascular Drugs and Therapy|December 31, 2003
Impact of statins on novel risk markersAndrea Cignarella, Chiara Bolego, Rodolfo PaolettiCardiovascular Drugs and Therapy|October 1, 1992
Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humansL Bergfeldt, K Schenck-Gustafsson, R DahlqvistCardiovascular Drugs and Therapy|August 1, 1992
Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandilL J van Woerkens, N R Baas, W J van der Giessen, et al.Cardiovascular Drugs and Therapy|June 1, 1992
Exercise tolerance with nebivolol and atenololL M Van Bortel, M A van BaakCardiovascular Drugs and Therapy|August 1, 1992
Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjectsT Mori, K Handa, Y Terao, et al.Cardiovascular Drugs and Therapy|April 1, 1992
Evaluation of bepridil efficacy by electrophysiologic testing in patients with recurrent ventricular tachycardia: comparison of two regimensB Brembilla-Perrot, E Aliot, J Clementy, et al.Cardiovascular Drugs and Therapy|November 18, 2003
The protective effects of monophosphoryl lipid A on the ischemic myocardium and endothelium in ratsHui-Qing Zhu, Jun-Lin Jiang, Rong Lu, et al.Cardiovascular Drugs and Therapy|August 1, 1992
The total ischemic burden European trial (TIBET): design, methodology, and management. The TIBET Study GroupCardiovascular Drugs and Therapy|August 1, 1992
Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of toleranceH H Erlemeier, W Kupper, W BleifeldPageof 302